Vivani Medical, Inc. (VANI) Stock Forecast
VANI analyst forecast
as of October 17, 2026- Analyst consensus
- Strong buy 4.67 / 5 from 3 analysts
- Price target
- $3.83 average of analyst targets
- Upside to target
- +242.3% from the latest close
- Next earnings
- November 12, 2026 EPS estimate $-0.07
- 52-week range
- $0.94 – $1.87
VANI analyst ratings
3 analystsNumber of analysts at each rating.
VANI price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
VANI earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.09 | −$0.09 | −$0.09 | −$0.11 | +18.2% | 2 |
| Current fiscal year (2026) | −$0.33 | −$0.33 | −$0.33 | −$0.43 | +23.3% | 2 |
| Next fiscal year (2027) | −$0.39 | −$0.54 | −$0.27 | −$0.33 | −19.2% | 3 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
VANI revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | 0.0% | 2 |
| Current fiscal year (2026) | $0 | $0 | $0 | 0.0% | 2 |
| Next fiscal year (2027) | $0 | $0 | $0 | 0.0% | 2 |
VANI EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
VANI EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.09 | −$0.09 | −$0.08 | −$0.08 | −$0.09 | 0.0% | 0 up · 0 down |
| Current fiscal year (2026) | −$0.36 | −$0.36 | −$0.34 | −$0.34 | −$0.33 | −8.3% | 2 up · 0 down |
| Next fiscal year (2027) | −$0.40 | −$0.40 | −$0.44 | −$0.44 | −$0.39 | −1.7% | 2 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
VANI earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; VANI beat in 10 of 12.
What analysts expect from VANI
3 analysts cover Vivani Medical; their consensus rating is strong buy (4.67 on a 1–5 scale, where 5 is a strong buy). The average price target is $3.83, 242.3% above the latest close of $1.12. Analysts expect earnings of −$0.33 per share for 2026, +23.3% from a year earlier. For 2027 the average estimate is −$0.39 per share. Vivani Medical beat the EPS estimate in 10 of the last 12 quarters.
Related: VANI income statement, VANI key metrics, VANI chart. See the VANI stock overview for the latest quote and news.
VANI forecast FAQ
What is Vivani Medical's price target?
The average analyst price target for Vivani Medical is $3.83, 242.3% above the latest close of $1.12.
Is Vivani Medical a buy, hold or sell?
Of 3 analysts covering Vivani Medical, 2 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Vivani Medical's EPS forecast?
Analysts forecast −$0.33 per share for 2026 (range −$0.33 to −$0.33); for 2027 the estimate is −$0.39.
When does Vivani Medical report earnings?
Vivani Medical is expected to report results for the quarter ending September 30, 2026 on November 12, 2026 after the market closes; the EPS estimate is $-0.07.
Does Vivani Medical usually beat earnings estimates?
Vivani Medical reported EPS at or above the analyst estimate in 10 of the last 12 quarters.